In a report released today, Brian Quast from BMO Capital maintained a Buy rating on B2Gold, with a price target of C$7.50. The company’s shares opened today at $3.80. Take advantage of TipRanks ...

B2Gold nears major growth with the Goose Mine launch, sector-low valuation, and strong cash flow amid high gold prices. Find ...

Strong growth in the energy segment and hi-tech manufacturing, propelled Larsen & Toubro (L&T) to report a 30 per cent jump in consolidated net profit for the quarter ended June 30, 2025, and a 15.5 ...

Caledonia Mining is fairly valued after a 130% YTD rally, with most upside now priced in and Zimbabwe risk remaining.

Brazilian bank BTG Pactual has acquired the Uruguayan operations of British bank HSBC for US$175 million, marking BTG Pactual ...

Brazilian bank BTG Pactual announced on Monday it agreed to buy HSBC operations in Uruguay for $175 million, the former investment bank’s first foray into a Spanish-speaking nation. Under regulatory ...

MacRury covers the Basic Materials sector, focusing on stocks such as Alamos Gold, Franco-Nevada, and B2Gold. According to TipRanks, MacRury has an average return of 17.9% and a 65.98% success rate on ...

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

LONDON (Alliance News) - BTG PLC said Thursday it has entered into a second non-disclosure agreement with US medical manufacturing giant Boston Scientific Corp.